B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells
Authors
Keywords
-
Journal
Cells
Volume 11, Issue 9, Pages 1448
Publisher
MDPI AG
Online
2022-04-26
DOI
10.3390/cells11091448
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B7-H4 induces epithelial–mesenchymal transition and promotes colorectal cancer stemness
- (2021) Ying Feng et al. PATHOLOGY RESEARCH AND PRACTICE
- Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas
- (2021) Na Niu et al. HUMAN PATHOLOGY
- PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects
- (2021) Enrico Munari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor–based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care
- (2021) Jens Bedke et al. EUROPEAN UROLOGY
- The Therapeutic Landscape of Renal Cell Carcinoma: From the Dark Age to the Golden Age
- (2020) Jennifer J. Huang et al. SEMINARS IN NEPHROLOGY
- B7-H4 is a potential prognostic biomarker of prostate cancer
- (2020) Haoyue Li et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a real-world setting
- (2020) Börje Ljungberg et al. Scandinavian Journal of Urology
- The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment
- (2020) Katie Hudson et al. Frontiers in Immunology
- A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma
- (2019) Caroline E. Nunes-Xavier et al. Current Urology Reports
- Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
- (2019) Lujun Chen et al. Cancer Cell International
- B7-H3 immune checkpoint protein in human cancer
- (2019) Karine Flem-Karlsen et al. CURRENT MEDICINAL CHEMISTRY
- p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
- (2019) Karine Flem-Karlsen et al. Scientific Reports
- The Changing Therapeutic Landscape of Metastatic Renal Cancer
- (2019) Javier C. Angulo et al. Cancers
- B7-H4, a promising target for immunotherapy
- (2019) Jia-Yu Wang et al. CELLULAR IMMUNOLOGY
- B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
- (2018) Ling Wang et al. Cancer Cell International
- Better Together: B7S1 Checkpoint Blockade Synergizes with anti-PD1
- (2018) Melissa A. Meyer et al. IMMUNITY
- DUSP5 expression associates with poor prognosis in human neuroblastoma
- (2018) Olaia Aurtenetxe et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma
- (2018) Takeshi Azuma et al. PLoS One
- B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer
- (2017) Lingwei Shen et al. HUMAN PATHOLOGY
- New B7 Family Checkpoints in Human Cancers
- (2017) Ling Ni et al. MOLECULAR CANCER THERAPEUTICS
- Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells
- (2017) Karine Flem-Karlsen et al. Pigment Cell & Melanoma Research
- Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma
- (2016) FEIFEI WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Choosing the right cell line for renal cell cancer research
- (2016) Klaudia K. Brodaczewska et al. Molecular Cancer
- Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors
- (2016) Caroline E. Nunes-Xavier et al. Oncotarget
- Cancer cell-associated cytoplasmic B7–H4 is induced by hypoxia through hypoxia-inducible factor-1α and promotes cancer cell proliferation
- (2015) You-Kyoung Jeon et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: From the patient's bed to molecular mechanisms
- (2013) Magdalena Buczek et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus
- (2013) L Zhang et al. ONCOGENE
- Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors
- (2013) Zhen-ye Li et al. OncoTargets and Therapy
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search